The Category 2 Ban and the 2026 Reclassification In 2023, the FDA pulled 19 of the most popular peptides BPC-157, TB-500, CJC-1295, among others off the compounding-permitted list and placed them on the restricted Category 2 list, citing safety concerns, impurity issues, and a lack of clinical data
It can help you fight dry mouth and keep things flowing
Employers organized to create plans that allowed their workers access to groups of physicians and individual practitioners for a monthly fee
It also: Suppresses lipolysis (fat breakdown) Inhibits hepatic ketogenesis When insulin doses are reduced even slightly the liver may increase ketone production
Martin B, Dotson CD, Shin Y-K, Ji S, Drucker DJ, Maudsley S, et al
PMID 21756963